alovudine has been researched along with cyclin d1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aboagye, EO; Aigbirhio, FI; Golovko, O; He, Q; Lees, M; Leyton, J; Nguyen, QD; Perumal, M; Smith, G; Workman, P | 1 |
| Fu, Z; Han, A; Mu, D; Sun, X; Yang, W; Yu, J; Zhang, Y | 1 |
1 trial(s) available for alovudine and cyclin d1
| Article | Year |
|---|---|
Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cyclin D1; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
1 other study(ies) available for alovudine and cyclin d1
| Article | Year |
|---|---|
Noninvasive imaging of cell proliferation following mitogenic extracellular kinase inhibition by PD0325901.
Topics: Animals; Benzamides; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dideoxynucleosides; Diphenylamine; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; MAP Kinase Kinase 1; Mice; Mice, Inbred BALB C; Phosphorylation; Positron-Emission Tomography; RNA, Messenger; Thymidine Kinase; Xenograft Model Antitumor Assays | 2008 |